Cite

HARVARD Citation

    Zhou, X. et al. (2016). Real-world outcome and healthcare costs of relapsed or refractory multiple myeloma: A retrospective analysis from the Chinese experience. Hematology. 21 (5), pp. 280-286. [Online]. 
  
Back to record